The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, P. aeruginosa can quickly develop resistance to various antibiotics, including aminoglycosides, quinolones, and β-lactams.224”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [224]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Cationic peptides: a new source of antibiotics
Hancock, R. E. W., & Lehrer, R. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01156-6 · Cited by 1,336
Self-citationIntermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
A Dose-Response Study of Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
Brooun, A., Liu, S., & Lewis, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.640-646.2000 · Cited by 473
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
Self-citationAntibiotic Resistance Caused by Gram‐Negative Multidrug Efflux Pumps
Nikaido, H. (1998) · Clinical Infectious Diseases · doi:10.1086/514920 · Cited by 348
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Self-citationThe role of natural environments in the evolution of resistance traits in pathogenic bacteria
Martinez, J. L. (2009) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2009.0320 · Cited by 513
de la Fuente-Núñez, C., Korolik, V., Bains, M., Nguyen, U., Breidenstein, E. B. M., Horsman, S., Lewenza, S., Burrows, L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00064-12 · Cited by 459
Self-citationEvolution and spread of antibiotic resistance
Normark, B. H., & Normark, S. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01026.x · Cited by 440
Safdar, N., Handelsman, J., & Maki, D. G. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01108-9 · Cited by 417
Ochsner, U. A., Wilderman, P. J., Vasil, A. I., & Vasil, M. L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03084.x · Cited by 403
ExsE, a secreted regulator of type III secretion genes in Pseudomonas aeruginosa
Rietsch, A., Vallet-Gely, I., Dove, S. L., & Mekalanos, J. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503005102 · Cited by 374
The Neglected Intrinsic Resistome of Bacterial Pathogens
Fajardo, A., Martínez-Martín, N., Mercadillo, M., Galán, J. C., Ghysels, B., Matthijs, S., Cornelis, P., Wiehlmann, L., Tümmler, B., Baquero, F., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001619 · Cited by 367
Overhage, J., Bains, M., Brazas, M. D., & Hancock, R. E. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01659-07 · Cited by 358
Self-citationGooderham, W. J., & Hancock, R. E. W. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00135.x · Cited by 346
Self-citationWinstanley, C., Langille, M. G. I., Fothergill, J. L., Kukavica-Ibrulj, I., Paradis-Bleau, C., Sanschagrin, F., Thomson, N. R., Winsor, G. L., Quail, M. A., Lennard, N., et al. (2009) · Genome Research · doi:10.1101/gr.086082.108 · Cited by 339
Self-citationFernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Self-citationFunction of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Self-citationResistance in nonfermenting gram-negative bacteria: Multidrug resistance to the maximum
McGowan, J. E. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.226 · Cited by 312
Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence
Davies, J. C. (2002) · Paediatric Respiratory Reviews · doi:10.1016/s1526-0550(02)00003-3 · Cited by 300
Liquid-Infused Silicone As a Biofouling-Free Medical Material
MacCallum, N., Howell, C., Kim, P., Sun, D., Friedlander, R., Ranisau, J., Ahanotu, O., Lin, J. J., Vena, A., Hatton, B., et al. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/ab5000578 · Cited by 289
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01698 · Cited by 258
Multidrug Efflux Systems Play an Important Role in the Invasiveness of Pseudomonas aeruginosa
Hirakata, Y., Srikumar, R., Poole, K., Gotoh, N., Suematsu, T., Kohno, S., Kamihira, S., Hancock, R. E. W., & Speert, D. P. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020005 · Cited by 256
Self-citationPseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
Wood, S. J., Kuzel, T. M., & Shafikhani, S. H. (2023) · Cells · doi:10.3390/cells12010199 · Cited by 254
Klebba, P. E., Newton, S. M. C., Six, D. A., Kumar, A., Yang, T., Nairn, B. L., Munger, C., & Chakravorty, S. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01005 · Cited by 150
Pletzer, D., Braun, Y., & Weingart, H. (2016) · Antonie van Leeuwenhoek · doi:10.1007/s10482-016-0675-8 · Cited by 29
Chellaiah, E. R., Ravi, P., & Uthandakalaipandian, R. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00867-z · Cited by 16
Liu, J., Ren, A., Miao, Z., Zhou, T., Zhang, C., Chang, Y., Zhao, S., Hu, X., Zhang, X., Jia, T., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00871-y
Metadata
- Authors
- Hancock, R. E. W., & Speert, D. P.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 3
- Issue
- 4
- Pages
- 247-255
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2171452890
- Cited by
- 515
- References
- 47
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.